Company: PACB
Filing Date: 2025-04-09
Form Type: 8-K
Source: 0001299130-25-000083
Chunk: 0

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-04-09
Form: 8-K
Item: Item 2.02
Chunk 0
---
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION.

On April 9, 2025, Pacific Biosciences of California, Inc. (the “ Company”) issued a press release providing a business update, including workforce reductions, and announcing certain unaudited preliminary financial results as of and for the quarter ended March 31, 2025 (the “ Press Release”). A copy of the Press Release is furnished hereto as Exhibit 99.1 and is incorporated by reference herein.

The information in Item 2.02 of this Current Report on Form 8-K, and the exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), nor incorporated by reference in any filing under the Securities Act of 1933, as amended (the “ Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Because the Company’s financial statements as of and for the quarter ended March 31, 2025 have not yet been finalized and remain subject to change, the Company’s final results for such period may differ materially from the unaudited preliminary financial information included in the Press Release. Accordingly, you should not place undue reliance on the unaudited preliminary financial information included in the Press Release.